Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I study of UTTR1147A (IL-22Fc), a potential therapy for epithelial injury in healthy volunteers.

Trial Profile

Phase I study of UTTR1147A (IL-22Fc), a potential therapy for epithelial injury in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jul 2018

At a glance

  • Drugs RG 7880 (Primary) ; RG 7880 (Primary)
  • Indications Diabetic foot ulcer; Ulcerative colitis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 22 Jul 2018 New trial record
    • 28 Jun 2018 Results published in the Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top